These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 15112444

  • 1. [Primary central nervous system lymphoma: diagnosis, management and current topics].
    Arita N.
    No To Shinkei; 2004 Mar; 56(3):195-203. PubMed ID: 15112444
    [No Abstract] [Full Text] [Related]

  • 2. Primary CNS lymphoma: a clinician's guide.
    Schäfer N, Glas M, Herrlinger U.
    Expert Rev Neurother; 2012 Oct; 12(10):1197-206. PubMed ID: 23082736
    [Abstract] [Full Text] [Related]

  • 3. Current management of primary central nervous system lymphoma.
    Schultz CJ, Bovi J.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):666-78. PubMed ID: 20159361
    [Abstract] [Full Text] [Related]

  • 4. Primary central nervous system lymphoma: recent progress, many remaining questions.
    Swinnen LJ.
    Curr Opin Oncol; 2009 Sep 01; 21(5):393-6. PubMed ID: 19593137
    [Abstract] [Full Text] [Related]

  • 5. [Not Available].
    Hoang-Xuan K.
    Bull Acad Natl Med; 2015 Nov 01; 199(8-9):1331. PubMed ID: 29874422
    [No Abstract] [Full Text] [Related]

  • 6. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K, Thiel E.
    Expert Rev Neurother; 2009 Oct 01; 9(10):1497-509. PubMed ID: 19831839
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic management of primary CNS lymphoma in immunocompetent patients.
    Reni M, Ferreri AJ.
    Expert Rev Anticancer Ther; 2001 Oct 01; 1(3):382-94. PubMed ID: 12113105
    [Abstract] [Full Text] [Related]

  • 8. Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma.
    Elkiran ET, Altundag K, Aksoy S, Onal IK, Tekuzman G.
    Am J Hematol; 2004 Apr 01; 75(4):265. PubMed ID: 15054831
    [No Abstract] [Full Text] [Related]

  • 9. Low-grade central nervous system lymphoma: clarity through a hazy lens.
    Hauser SL.
    Ann Neurol; 2006 May 01; 59(5):9A-10A. PubMed ID: 16634011
    [No Abstract] [Full Text] [Related]

  • 10. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G, Müller F, Feuerhake F, Schäfer AO, Ostertag C, Finke J.
    Haematologica; 2008 Jan 01; 93(1):147-8. PubMed ID: 18166803
    [Abstract] [Full Text] [Related]

  • 11. Primary central nervous system lymphoma.
    Mohile NA, Abrey LE.
    Neurol Clin; 2007 Nov 01; 25(4):1193-207, xi. PubMed ID: 17964031
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of primary central nervous system lymphoma in the immunocompetent patient].
    Sierra Del Rio M, Benouaich-Amiel A, Psimaras D, Dehais C, Hoang-Xuan K.
    Rev Neurol (Paris); 2008 Nov 01; 164(6-7):569-74. PubMed ID: 18565356
    [Abstract] [Full Text] [Related]

  • 13. Primary central nervous system (CNS) lymphoma in immunocompetent patients.
    Plasswilm L, Herrlinger U, Korfel A, Weller M, Küker W, Kanz L, Thiel E, Bamberg M.
    Ann Hematol; 2002 Aug 01; 81(8):415-23. PubMed ID: 12223997
    [Abstract] [Full Text] [Related]

  • 14. Primary central nervous system lymphoma: biological aspects and controversies in management.
    Bessell EM, Hoang-Xuan K, Ferreri AJ, Reni M.
    Eur J Cancer; 2007 May 01; 43(7):1141-52. PubMed ID: 17433666
    [Abstract] [Full Text] [Related]

  • 15. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Goldstein DA, Tessler HH.
    Am J Ophthalmol; 2007 Dec 01; 144(6):976; author reply 976. PubMed ID: 18036877
    [No Abstract] [Full Text] [Related]

  • 16. [Management of primary central nervous system lymphoma].
    Gonzalez-Aguilar A, Houillier C, Soussain C, Hoang-Xuan K.
    Rev Neurol (Paris); 2011 Oct 01; 167(10):721-8. PubMed ID: 21906768
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of central nervous system malignant lymphoma].
    Nakamura O.
    No To Shinkei; 2005 Dec 01; 57(12):1043-9. PubMed ID: 16375189
    [No Abstract] [Full Text] [Related]

  • 18. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
    Shenkier TN, Voss N, Chhanabhai M, Fairey R, Gascoyne RD, Hoskins P, Klasa R, Morris J, O'Reilly SE, Pickles T, Sehn L, Connors JM.
    Cancer; 2005 Mar 01; 103(5):1008-17. PubMed ID: 15651059
    [Abstract] [Full Text] [Related]

  • 19. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM, Ribera JM, Oriol A, Hernandez-Rivas JM, Rivas C, Bethencourt C, Parody R, Deben G, Bello JL, Feliu E, Programa para el Estudio y Tratamiento de Hemopatias Malignas Group.
    Cancer; 2006 Jun 15; 106(12):2540-6. PubMed ID: 16700036
    [Abstract] [Full Text] [Related]

  • 20. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Yamanaka R, Morii K, Shinbo Y, Takeuchi S, Tamura T, Hondoh H, Takahashi H, Onda K, Takahashi H, Tanaka R.
    Ann Hematol; 2005 Jul 15; 84(7):447-55. PubMed ID: 15747120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.